Adocia SAS Accelerates Diabetes Therapy with BioChaperone Platform Amid Market Volatility
Adocia SAS pushes biotech frontiers with its BioChaperone platform, creating ultra‑rapid insulin and GLP‑1 combos to tackle diabetes and metabolic disorders.
3 minutes to read